Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

69 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immunogenicity and safety of MF59-adjuvanted and full-dose unadjuvanted trivalent inactivated influenza vaccines among vaccine-naïve children in a randomized clinical trial in rural Senegal.
Diallo A, Victor JC, Feser J, Ortiz JR, Kanesa-Thasan N, Ndiaye M, Diarra B, Cheikh S, Diene D, Ndiaye T, Ndiaye A, Lafond KE, Widdowson MA, Neuzil KM. Diallo A, et al. Among authors: lafond ke. Vaccine. 2018 Oct 15;36(43):6424-6432. doi: 10.1016/j.vaccine.2018.08.032. Epub 2018 Sep 14. Vaccine. 2018. PMID: 30224199 Free PMC article. Clinical Trial.
Effectiveness of Seasonal Influenza Vaccination in Children in Senegal During a Year of Vaccine Mismatch: A Cluster-randomized Trial.
Diallo A, Diop OM, Diop D, Niang MN, Sugimoto JD, Ortiz JR, Faye EHA, Diarra B, Goudiaby D, Lewis KDC, Emery SL, Zangeneh SZ, Lafond KE, Sokhna C, Halloran ME, Widdowson MA, Neuzil KM, Victor JC. Diallo A, et al. Among authors: lafond ke. Clin Infect Dis. 2019 Oct 30;69(10):1780-1788. doi: 10.1093/cid/ciz066. Clin Infect Dis. 2019. PMID: 30689757 Free PMC article. Clinical Trial.
Supporting national immunization technical advisory groups (NITAGs) in resource-constrained settings. New strategies and lessons learned from the Task Force for Global Health's Partnership for influenza vaccine introduction.
Ba-Nguz A, Shah A, Bresee JS, Lafond KE, Cavallaro K, Shefer A, Donadel M, Seward JF. Ba-Nguz A, et al. Among authors: lafond ke. Vaccine. 2019 Jun 19;37(28):3646-3653. doi: 10.1016/j.vaccine.2019.05.046. Epub 2019 May 23. Vaccine. 2019. PMID: 31130258 Free PMC article.
Efficacy of inactivated trivalent influenza vaccine in rural India: a 3-year cluster-randomised controlled trial.
Sullender WM, Fowler KB, Gupta V, Krishnan A, Ram Purakayastha D, Srungaram Vln R, Lafond KE, Saha S, Palomeque FS, Gargiullo P, Jain S, Lal R, Widdowson MA, Broor S. Sullender WM, et al. Among authors: lafond ke. Lancet Glob Health. 2019 Jul;7(7):e940-e950. doi: 10.1016/S2214-109X(19)30079-8. Lancet Glob Health. 2019. PMID: 31200893 Free PMC article. Clinical Trial.
The partnership for influenza vaccine introduction (PIVI): Supporting influenza vaccine program development in low and middle-income countries through public-private partnerships.
Bresee JS, Lafond KE, McCarron M, Azziz-Baumgartner E, Chu SY, Ebama M, Hinman AR, Xeuatvongsa A, Bino S, Richardson D, Porter RM, Moen A, McKinlay M; PIVI Partners Group. Bresee JS, et al. Among authors: lafond ke. Vaccine. 2019 Aug 14;37(35):5089-5095. doi: 10.1016/j.vaccine.2019.06.049. Epub 2019 Jul 6. Vaccine. 2019. PMID: 31288998 Free PMC article.
69 results